ResMed | RMD - Current Assets

Stock Price
260.92
Daily Change
1.80 0.69%
Monthly
2.13%
Yearly
13.62%
Q1 Forecast
251.09

ResMed reported $3.82B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Ansell USD 1.11B 513.1M Jun/2025
Artivion USD 337.5M 18.68M Sep/2025
AtriCure USD 322.52M 21.41M Dec/2025
Baxter International USD 6.87B 61M Dec/2025
Cochlear AUD 1.42B 6.2M Jun/2025
Cooper Companies USD 2.11B 31.4M Sep/2025
CSL USD 11.85B 542M Jun/2025
Dexcom USD 4.03B 1.19B Dec/2025
Edwards Lifesciences USD 6.36B 218.3M Sep/2025
Fisher Paykel Healthcare NZD 983.7M 48.3M Dec/2025
Globus Medical USD 1.92B 194.46M Sep/2025
Haemonetics USD 943.67M 43.99M Dec/2025
Hologic USD 3.84B 175.3M Dec/2025
Idexx Laboratories USD 1.41B 63.23M Dec/2025
Inogen USD 203.72M 594K Sep/2025
Insulet USD 1.91B 54.6M Dec/2025
Integra LifeSciences USD 1.14B 754K Sep/2025
Intuitive Surgical USD 12.4B 927.3M Dec/2025
Masimo USD 1.05B 221.5M Sep/2025
Medtronic USD 24B 773M Sep/2025
Philips EUR 9.93B 654M Dec/2025
Ramsay Health Care AUD 4.04B 632.8M Jun/2025
ResMed USD 3.82B 193.06M Dec/2025
Sigma Healthcare AUD 2.91B 2B Dec/2025
Sonic Healthcare AUD 2.3B 52.76M Dec/2024
Steris USD 2.29B 179.9M Dec/2025
Teleflex USD 1.99B 262.12M Sep/2025
Thermo Fisher Scientific USD 28.71B 6.41B Dec/2025